Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302129 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Daniel R Zollinger und 32 weiteren Autor:innen. Beteiligte Einrichtung: Foundation Medicine Inc, Cambridge, MA, United States of America. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Medicine, Natera, F. Hoffmann-La Roche.
Abstract (Originalsprache)
Emerging technologies focused on the detection and quantification of circulating tumor DNA (ctDNA) in blood show extensive potential for managing patient treatment decisions, informing risk of recurrence, and predicting response to therapy. Currently available tissue-informed approaches are often limited by the need for additional sequencing of normal tissue or peripheral mononuclear cells to identify non-tumor-derived alterations while tissue-naïve approaches are often limited in sensitivity. Here we present the analytical validation for a novel ctDNA monitoring assay, FoundationOne®Tracker. The assay utilizes somatic alterations from comprehensive genomic profiling (CGP) of tumor tissue. A novel algorithm identifies monitorable alterations with a high probability of being somatic and computationally filters non-tumor-derived alterations such as germline or clonal hematopoiesis variants without the need for sequencing of additional samples. Monitorable alterations identified from tissue CGP are then quantified in blood using a multiplex polymerase chain reaction assay based on the validated Signatera TM assay. The analytical specificity of the plasma workflow is shown to be 99.6% at the sample level. Analytical sensitivity is shown to be >97.3% at ≥5 mean tumor molecules per mL of plasma (MTM/mL) when tested with the most conservative configuration using only two monitorable alterations. The assay also demonstrates high analytical accuracy when compared to liquid biopsy-based CGP as well as high qualitative (measured 100% PPA) and quantitative precision (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Foundation Medicine Inc, Cambridge, MA, United States of America.
- Natera, Austin, TX, United States of America.
- Roche/Genentech, South San Francisco, CA, United States of America.
- Barts Cancer Institute, Barts Experimental Cancer Medicine Centre, Queen Mary University of London, Barts Health, London, United Kingdom.
ORCID-Profile: Daniel R Zollinger, Dorhyun Johng, Pratyush Gupta, Amanda Young
Förderung
- Foundation Medicine
- Natera
- F. Hoffmann-La Roche
Zitieren
APA
Zollinger, D. R., Rivers, E., Fine, A., Huang, Y., Son, J., Kalyan, A., Gray, W., Baharian, G., Hammond, C., Ram, R., Ringman, L., Hafez, D., Savel, D., Patel, V., Dantone, M., Guo, C., Childress, M., Xu, C., Johng, D., …, & Young, A. (2024). Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors. PLOS ONE. https://doi.org/10.1371/journal.pone.0302129
Vancouver
Zollinger DR, Rivers E, Fine A, Huang Y, Son J, Kalyan A, et al. Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors. PLOS ONE. 2024. doi:10.1371/journal.pone.0302129
BibTeX
@article{Zollinger2024,
author = {Zollinger, Daniel R and Rivers, Elizabeth and Fine, Alexander and Huang, Yanmei and Son, Joseph and Kalyan, Akshita and Gray, Wren and Baharian, Golshid and Hammond, Carly and Ram, Rosalyn and Ringman, Lindsay and Hafez, Dina and Savel, Daniel and Patel, Vipul and Dantone, Marc and Guo, Cui and Childress, Merrida and Xu, Chang and Johng, Dorhyun and Wallden, Brett and Pokharel, Prapti and Camara, William and Hegde, Priti S and Hughes, Jason and Carter, Corey and Davarpanah, Nicole and Degaonkar, Viraj and Gupta, Pratyush and Mariathasan, Sanjeev and Powles, Thomas and Ferree, Sean and Dennis, Lucas and Young, Amanda},
title = {Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302129}
}
EUVIMED